Yes.
And if Amgen did have even one such drug, they would already be conducting a combo clinical trial with Kyprolis.
Ann: Bisantrene Highly Active in a Multiple Myeloma Mouse Model, page-58
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.63 |
Change
-0.050(2.98%) |
Mkt cap ! $284.5M | |||
| Open | High | Low | Value | Volume |
| $1.67 | $1.67 | $1.61 | $148.8K | 91.89K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2602 | $1.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.63 | 101 | 2 |
View Market Depth
| Last trade - 14.10pm 09/09/2024 (20 minute delay) ? |
| RAC (ASX) Chart |